Skip to main content
TipRanks
Go Ultimate75% OFF

Compare TG Therapeutics (NKB2) vs. Competitors

3 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:NKB2TG TherapeuticsEUR 58.20EUR 8.85B86.60115.36%Moderate BuyUnlock the DE:NKB2 analyst price target with TipRanks PremiumDE:NKB2Unlock the DE:NKB2 top-analyst price target with TipRanks Premium
PTGXProtagonist Therapeutics$130.95$8.55B25.3957.32%Strong BuyUnlock the PTGX analyst price target with TipRanks PremiumDE:NKB2 vs PTGXUnlock the PTGX top-analyst price target with TipRanks Premium
IMVTImmunovant$34.18$7.07B-13.3549.78%Moderate BuyUnlock the IMVT analyst price target with TipRanks PremiumDE:NKB2 vs IMVTUnlock the IMVT top-analyst price target with TipRanks Premium
ARQTArcutis Biotherapeutics$28.26$3.57B121.4423.62%Strong BuyUnlock the ARQT analyst price target with TipRanks PremiumDE:NKB2 vs ARQTUnlock the ARQT top-analyst price target with TipRanks Premium
LEGNLegend Biotech$17.50$3.39B-1750.00-43.57%Moderate BuyUnlock the LEGN analyst price target with TipRanks PremiumDE:NKB2 vs LEGNUnlock the LEGN top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$127.57$10.89B-35.14100.49%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumDE:NKB2 vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:NKB2TG Therapeutics58.2031.78120.29%
PTGXProtagonist Therapeutics130.9546.1854.48%
IMVTImmunovant34.189.8840.66%
ARQTArcutis Biotherapeutics28.262.097.99%
LEGNLegend Biotech17.50-12.22-41.12%
KYMRKymera Therapeutics127.5763.4799.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts